| Application number | Title of the application | Filing Date | Status |
|---|
| 09/523552 | Novel interleukin- 1 receptor antagonist and uses thereof | Mar 9, 2000 | Abandoned |
| 09/519728 | Mutants of thyroid stimulating hormone and methods based thereon | Mar 2, 2000 | Abandoned |
| 09/514587 | Fibroblast growth factor 11 | Feb 27, 2000 | Abandoned |
Array
(
[id] => 1192071
[patent_doc_number] => 06730303
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-04
[patent_title] => 'Fused G-CSF and IL-3 proteins and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/510238
[patent_app_country] => US
[patent_app_date] => 2000-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 71058
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/730/06730303.pdf
[firstpage_image] =>[orig_patent_app_number] => 09510238
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/510238 | Fused G-CSF and IL-3 proteins and uses thereof | Feb 21, 2000 | Issued |
Array
(
[id] => 6739734
[patent_doc_number] => 20030157103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Human amine transporter antibodies'
[patent_app_type] => new
[patent_app_number] => 09/502018
[patent_app_country] => US
[patent_app_date] => 2000-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11584
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157103.pdf
[firstpage_image] =>[orig_patent_app_number] => 09502018
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/502018 | Human amine transporter antibodies | Feb 10, 2000 | Issued |
Array
(
[id] => 648935
[patent_doc_number] => 07115390
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-10-03
[patent_title] => 'Connective tissue growth factor fragments and methods and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/461646
[patent_app_country] => US
[patent_app_date] => 1999-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17248
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115390.pdf
[firstpage_image] =>[orig_patent_app_number] => 09461646
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/461646 | Connective tissue growth factor fragments and methods and uses thereof | Dec 13, 1999 | Issued |
Array
(
[id] => 1594948
[patent_doc_number] => 06492129
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Fragments of connective tissue growth factor that induce extracellular matrix synthesis, collagen synthesis and/or myofibroblast differentiation'
[patent_app_type] => B1
[patent_app_number] => 09/461688
[patent_app_country] => US
[patent_app_date] => 1999-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19800
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/492/06492129.pdf
[firstpage_image] =>[orig_patent_app_number] => 09461688
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/461688 | Fragments of connective tissue growth factor that induce extracellular matrix synthesis, collagen synthesis and/or myofibroblast differentiation | Dec 13, 1999 | Issued |
Array
(
[id] => 6655820
[patent_doc_number] => 20030077652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'ANTIBODIES THAT SPECIFICALLY BIND RECEPTOR'
[patent_app_type] => new
[patent_app_number] => 09/457865
[patent_app_country] => US
[patent_app_date] => 1999-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12756
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077652.pdf
[firstpage_image] =>[orig_patent_app_number] => 09457865
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/457865 | Antibodies that specifically bind a Bacillus thuringiensis toxin receptor | Dec 9, 1999 | Issued |
Array
(
[id] => 1458453
[patent_doc_number] => 06426191
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-30
[patent_title] => 'Assays involving an IL-1 receptor antagonist'
[patent_app_type] => B1
[patent_app_number] => 09/457626
[patent_app_country] => US
[patent_app_date] => 1999-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 43040
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/426/06426191.pdf
[firstpage_image] =>[orig_patent_app_number] => 09457626
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/457626 | Assays involving an IL-1 receptor antagonist | Dec 7, 1999 | Issued |
Array
(
[id] => 4384804
[patent_doc_number] => 06294655
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-25
[patent_title] => 'Anti-interleukin-1 receptor antagonist antibodies and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 9/417455
[patent_app_country] => US
[patent_app_date] => 1999-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 43227
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/294/06294655.pdf
[firstpage_image] =>[orig_patent_app_number] => 417455
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/417455 | Anti-interleukin-1 receptor antagonist antibodies and uses thereof | Oct 12, 1999 | Issued |
| 09/419262 | METHODS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH INCREASED FAS-LIGAND TITERS | Oct 11, 1999 | Abandoned |
| 09/410349 | PLATELET-DERIVED GROWTH FACTOR C, DNA CODING THEREFOR, AND USES THEREOF | Sep 29, 1999 | Abandoned |
| 09/401429 | METHODS OF REDUCING OR MAINTAINING REDUCED LEVELS OF BLOOD LIPIDS USING OB PROTEIN COMPOSITIONS | Sep 21, 1999 | Abandoned |
| 09/393023 | HUMAN CRIPTIN GROWTH FACTOR | Sep 8, 1999 | Abandoned |
| 09/380138 | NOVEL POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME | Aug 24, 1999 | Abandoned |
Array
(
[id] => 8801924
[patent_doc_number] => 08440196
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-05-14
[patent_title] => 'Treatment for pancreatitis using IL-6 receptor antagonist antibodies'
[patent_app_type] => utility
[patent_app_number] => 09/762550
[patent_app_country] => US
[patent_app_date] => 1999-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 10960
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 09762550
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/762550 | Treatment for pancreatitis using IL-6 receptor antagonist antibodies | Aug 22, 1999 | Issued |
Array
(
[id] => 963526
[patent_doc_number] => 06949338
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-27
[patent_title] => 'Methods and kits for obtaining and analyzing skin samples for the detection of nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 09/375609
[patent_app_country] => US
[patent_app_date] => 1999-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8177
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/949/06949338.pdf
[firstpage_image] =>[orig_patent_app_number] => 09375609
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/375609 | Methods and kits for obtaining and analyzing skin samples for the detection of nucleic acids | Aug 16, 1999 | Issued |
Array
(
[id] => 4399809
[patent_doc_number] => 06264654
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-24
[patent_title] => 'Ablation catheter'
[patent_app_type] => 1
[patent_app_number] => 9/361811
[patent_app_country] => US
[patent_app_date] => 1999-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 7743
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/264/06264654.pdf
[firstpage_image] =>[orig_patent_app_number] => 361811
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/361811 | Ablation catheter | Jul 26, 1999 | Issued |
Array
(
[id] => 1535266
[patent_doc_number] => 06337072
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-08
[patent_title] => 'Interleukin-1 receptor antagonist and recombinant production thereof'
[patent_app_type] => B1
[patent_app_number] => 09/348942
[patent_app_country] => US
[patent_app_date] => 1999-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 41860
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/337/06337072.pdf
[firstpage_image] =>[orig_patent_app_number] => 09348942
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/348942 | Interleukin-1 receptor antagonist and recombinant production thereof | Jul 6, 1999 | Issued |
| 09/334809 | GLYCOPROTEIN HORMONE FAMILY MEMBER | Jun 16, 1999 | Abandoned |
